Revvity, Inc. (rvty)

RVTY — Company Overview

Investors tracking RVTY follow a Diagnostics & Research name listed on NYQ within Healthcare.

RVTY — Business Description

The business profile of Revvity, Inc. (RVTY) reflects its role in Diagnostics & Research. Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic…

Official website: https://www.revvity.com.

RVTY — Investment Thesis

Revvity, Inc. (RVTY) attracts investors weighing Diagnostics & Research fundamentals against current market pricing.

• Revenue is expanding at roughly 1.3% year-over-year (public data).
• Trailing P/E of 68.99× implies elevated growth expectations at the current price.
• Forward P/E (24.12×) is below trailing P/E — earnings may be expected to improve.
• Equity market capitalization is approximately $15.86B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

RVTY — Financial Health

RVTY financial profile reflects operating efficiency and capital structure using available market fundamentals.

Profit margin near 8.2% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $604.99M supports balance-sheet flexibility.

RVTY — Growth Outlook

Growth outlook for Revvity, Inc. (RVTY) depends on demand trends in Diagnostics & Research and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 1.3% suggests steady but measured expansion.
• Earnings growth of 1.2% year-over-year supports improving profitability.
• Price is 5.0% below the 52-week high.

RVTY — Competitive Position

Revvity, Inc. (RVTY) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Diagnostics & Research.
• Market capitalization of $15.86B places RVTY among large-cap peers.
• Gross margin near 55.0% may reflect pricing power or favorable mix.

RVTY — Summary

Revvity, Inc. (RVTY) is a large-cap Healthcare company focused on Diagnostics & Research, listed on NYQ. Last price $142.11 with market cap $15.86B. Trailing P/E 68.99×. Revenue grew 1.3% year-over-year per public data. Notable strengths include earnings growth of 1.2% year-over-year. Key watch items include elevated trailing p/e (68.99×) limits valuation margin of safety. Review free estimates and earnings pages for RVTY; upgrade for institutional ownership and live headlines.